Panling Xu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Signaling Pathway

Top Venues

Current cancer drug targets

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yiqi Du, Fenglin Zhang, Panling Xu, Ping Li
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Current cancer drug targets 24 (7) (2024)
Yiqi Du, Fenglin Zhang, Panling Xu, Ping Li
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Current cancer drug targets (2024)
Yiqi Du, Fenglin Zhang, Panling Xu, Ping Li
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Current cancer drug targets 24 (7) (2024)
Xin Sun, Panling Xu, Fengli Zhang, Ting Sun, Haili Jiang, Mei Zhang, Ping Li
Study on Mechanism of Yiqi Yangyin Jiedu Recipe Inhibiting Triple Negative Breast Cancer Growth: A Network Pharmacology and In Vitro Verification. Journal of oncology 2022 (2022)